Pediatrics Department, Ain Shams University, Cairo, Egypt.
Pediatr Blood Cancer. 2010 Jul 1;54(7):959-62. doi: 10.1002/pbc.22481.
Idiopathic thrombocytopenic purpura is a hematological disorder with heterogeneous manifestation and unpredictable outcome. This study reviewed the pattern of presentation and response to therapy in patients with ITP, in order to identify risk factors for chronic disease.
The study included all patients diagnosed as ITP between January 1998 and December 2007.
Sixty-five percent of the patients had acute and 34.9% had chronic ITP. Patients with chronic ITP had a higher mean age at diagnosis (P = 0.0000003). Females more than 10 years of age were more susceptible than males to follow a chronic course (P = 0.031). Febrile illness preceded the onset of ITP in 167 patients, 76.0% of them had an acute course (P = 0.000037). Moderate and severe bleeding occurred in 11.34% and 7.27% of the patients, respectively. Fifty-four patients (15.7%) improved without any specific treatment. Corticosteroids were used as a first-line treatment in 209 patients and showed a total response of 76.6% compared to 85.7% and 84% for IVIG and anti-D immunoglobulin treated patients, respectively.
The most relevant risk factors for the development of chronic ITP included a gradual mode of onset of symptoms over more than 2 weeks period, initial platelet count >20 x 10(9)/L, and age more than 10 years at presentation.
特发性血小板减少性紫癜是一种表现多样、预后不可预测的血液病。本研究回顾了 ITP 患者的表现模式和对治疗的反应,以确定慢性疾病的危险因素。
本研究纳入了 1998 年 1 月至 2007 年 12 月期间所有被诊断为 ITP 的患者。
65%的患者为急性 ITP,34.9%为慢性 ITP。慢性 ITP 患者的诊断年龄更高(P=0.0000003)。10 岁以上的女性比男性更容易发展为慢性 ITP(P=0.031)。167 例患者在 ITP 发病前有发热性疾病,其中 76.0%为急性病程(P=0.000037)。中度和重度出血分别发生在 11.34%和 7.27%的患者中。54 例(15.7%)患者未经任何特定治疗而自行改善。209 例患者一线使用皮质类固醇治疗,总缓解率为 76.6%,与 IVIG 和抗-D 免疫球蛋白治疗患者的 85.7%和 84%相比。
导致慢性 ITP 发展的最相关危险因素包括症状逐渐出现超过 2 周、初始血小板计数>20×10(9)/L 和就诊时年龄>10 岁。